Evidence map›Paper›PMID 32422939›Full record

ArticleVaccines2020

Prevalence, Genotype Distribution, and Predictors against HPV Infections Targeted by 2-, 4-, 9-Valent HPV Vaccines among Japanese Males.

Yukimasa Matsuzawa, Tadaichi Kitamura, Motofumi Suzuki, Yasuhiro Koyama, Kazuyoshi Shigehara

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yukimasa MatsuzawaDepartment of Urology, University of Tokyo Hospital, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID 0000-0002-8470-7796
Tadaichi KitamuraDepartment of Urology, University of Tokyo Hospital, Bunkyo-ku, Tokyo 113-0033, Japan.
Motofumi SuzukiDepartment of Urology, University of Tokyo Hospital, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID 0000-0003-2552-1964
Yasuhiro KoyamaDepartment of Urology, Asoka Hospital, Koto-ku, Tokyo 135-0002, Japan.
Kazuyoshi ShigeharaDepartment of Urology, Faculty of Medicine, Kanazawa University, Kanazawa 920-8641, Japan.
University of Tokyo Hospital · JPKanazawa University · JP

Funding

The Japanese Foundation for Sexual Health Medicine Heisei 29001
6 · The paper itself

Abstract

objectivesEpidemiological reports of sexual life and human papilloma virus (HPV) infection among Japanese men are scarce, and the necessity of HPV vaccines for males is regarded as a controversial topic in Japan. The objective of this study is to determine the prevalence, genotype distribution, and risk factors against HPV infections targeted by bivalent (2v), quadrivalent (4v), and 9-valent (9v) HPV vaccines among Japanese male patients who visited our urological clinics. MATERIAL AND

methodsThe study population consisted of 798 males aged 20 to 95 years (mean ± standard deviation, 55.4 ± 19.5 years). We collected scraping samples from the glans penis using cotton swabs from all patients for genotyping of HPVs. We compared patients' characteristics and detected HPV genotypes in order to determine the risk factors against HPV infections.

resultsOf 798 participants, 198 participants (198/798; 24.8%) had at least one genotype of any HPV infection. The total number of detected HPV genotypes was 328. Of 328 genotypes, 30% (n = 99; 99/328) were 9v HPV genotypes. Most frequently detected types of high-risk HPV infection were type 52 (n = 40; 40/328; 12.2%). Number of lifetime sex partners (≥21) and present or history of sexually transmitted infections were found to be predictors of any HPV infection with adjusted odds ratios of 3.106 (95% confidence interval (CI), 1.593-6.509) and 1.894 (95% CI, 1.185-3.026), respectively. Age of sex initiation was a predictor of 2v and 4v HPV infections with adjusted odds ratios of 100 (95% CI, 1.013-25.673) and 2.676 (95% CI, 1.037-6.905), respectively. Number of lifetime sex partners (≥21) was a predictor of 9v HPVs with adjusted odds ratios of 2.397 (95% CI, 1.060-5.424).

conclusionsApproximately, a quarter of Japanese male patients who visited urological clinics were exposed to HPV. Moreover, from the perspective of our multivariate logistic regression analysis, some kinds of sexual behavior aggravate the risk of typical HPV genotypes infections.

Indexed as

2v vaccine4v vaccine9v vaccineHPV vaccinehuman papillomavirus

Identifiers

PMID32422939
PMCPMC7349125
OpenAlexW3025548239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.